Key statistics
As of last trade Valneva SE (0OB3:LSE) traded at 4.16, -23.25% below its 52-week high of 5.42, set on Aug 18, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 4.16 |
| Low | 4.16 |
| Bid | -- |
| Offer | -- |
| Previous close | 4.05 |
| Average volume | 25.66k |
|---|---|
| Shares outstanding | 172.21m |
| Free float | 152.63m |
| P/E (TTM) | -- |
| Market cap | 709.52m EUR |
| EPS (TTM) | -0.5807 EUR |
Data delayed at least 20 minutes, as of Feb 10 2026 08:10 GMT.
More ▼
- VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026
- VALNEVA Declaration of shares and voting rights: January 31, 2026
- Valneva et l'Instituto Butantan annoncent le début d'une stratégie pilote de vaccination au Brésil avec le vaccin à injection unique IXCHIQ® contre le chikunguny
- Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®
- Valneva fait un point sur son vaccin contre le chikungunya IXCHIQ®
- Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
- Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
- Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference
- Valneva SE - Declaration of voting rights - December 2025
- Déclaration d'actions et de droits de vote de la société Valneva SE - décembre 2025
More ▼
